Research Headquarters
In VaxThera we have been strengthening our capabilities to do science and technology and position Colombia as a leader in the biotechnology and health industry.
Our vaccine and biologics research headquarters has 820 m2 built where we have state-of-the-art technology, highly qualified talent, and processes with the highest standards of quality.
Reproducir vídeo
Research headquarters
Play video
With the technology and quality of the laboratory facilities, VaxThera will be able to conduct rigorous research studies; design, produce, and validate vaccine candidates; optimize production processes; and generate high-quality vaccines and biologics for use in preclinical studies.
The laboratory complies with Good Laboratory Practices (GLP), thus ensuring the quality, integrity, and reliability of the processes. Also, as a result of the joint work with world-class companies such as Univercells and Quantoom, renowned for the manufacture of bioreactors and robotic equipment for the production of vaccines using viral vector and mRNA technologies, Colombia and the region will have access to state-of-the-art technologies used in the production of vaccines and biologics.
Learn more about our research and development pipeline here.